Cargando…

The association between nonselective beta-blockers and portal venous thrombosis in cirrhotic patients: More questions on the horizon

Detalles Bibliográficos
Autores principales:	Bartell, Nicholas, Al-Judaibi, Bandar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2018
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5848321/ https://www.ncbi.nlm.nih.gov/pubmed/29451177 http://dx.doi.org/10.4103/sjg.SJG_588_17

Ejemplares similares

The use of nonselective beta blockers is a risk factor for portal vein thrombosis in cirrhotic patients
por: Zampino, Rosa, et al.
Publicado: (2018)

Nonselective β-Blockers May Progress the Thrombosis of Portal Venous System in Cirrhotic Patients: A Retrospective Observational Study
por: Xu, Xiangbo, et al.
Publicado: (2020)

Beta-blocker therapy in refractory ascites: A steady march towards the truth
por: Bartell, Nicholas, et al.
Publicado: (2022)

Assessment of Haemodynamic Response to Nonselective Beta-Blockers in Portal Hypertension by Phase-Contrast Magnetic Resonance Angiography
por: McDonald, Natasha, et al.
Publicado: (2017)

Impact of selective and nonselective beta-blockers on the risk of severe exacerbations in patients with COPD
por: Huang, Yueh Lan, et al.
Publicado: (2017)

Nonselective beta-blocker use is associated with increased hepatic encephalopathy-related readmissions in cirrhosis
por: Fallahzadeh, Mohammad Amin, et al.
Publicado: (2022)

Evaluation of Coagulation, Fibrinolysis and Endothelial Biomarkers in Cirrhotic Patients With or Without Portal Venous Thrombosis
por: Ren, Wenhua, et al.
Publicado: (2020)

Management of Portal Vein Thrombosis in Cirrhotic Patients
por: Amitrano, Lucio, et al.
Publicado: (2009)

Nonselective Beta-Blockers for the Efficacious Healing of Ulcerated Infantile Hemangiomas in Unusual Locations of Two Female Infants
por: Poulose, Divya, et al.
Publicado: (2021)

Nonselective beta-adrenoceptor blocker use and risk of Parkinson’s disease: from multiple real-world evidence
por: Feng, Zeying, et al.
Publicado: (2023)

Non-cirrhotic portal vein thrombosis – therapeutic challenge
por: Sarquis, Lucas Mansano, et al.
Publicado: (2022)

Risk factors for portal vein thrombosis or venous thromboembolism in a large cohort of hospitalized cirrhotic patients
por: Faccia, Mariella, et al.
Publicado: (2022)

Increase in Free Hepatic Venous Pressure Response to Beta-Blockers Predicts Variceal Bleeding in Cirrhotic Patients
por: Guo, Huiwen, et al.
Publicado: (2021)

Carvedilol Versus Other Nonselective Beta Blockers for Variceal Bleeding Prophylaxis and Death: A Network Meta-analysis
por: Cheung, Ka-Shing, et al.
Publicado: (2023)

Changes in transient elastography in early cirrhotic patients after receiving nonselective B‐blocker for primary variceal bleeding prophylaxis: Three‐month follow up
por: Piyachaturawat, Panida, et al.
Publicado: (2018)

Hemodynamic Evaluation of Nonselective β-Blockers in Patients with Cirrhosis and Refractory Ascites
por: Ferrarese, Alberto, et al.
Publicado: (2018)

Autophagy: More Than a Nonselective Pathway
por: Reggiori, Fulvio, et al.
Publicado: (2012)

Association Between Nonselective Beta-Blocker Use and Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Without Cirrhosis and Decompensation
por: Cheng, He-Yun, et al.
Publicado: (2022)

Use of nonselective β blockers after variceal eradication in cirrhotic patients undergoing secondary prophylaxis of esophageal variceal bleeding: a critical review of current evidence
por: Xu, Xiangbo, et al.
Publicado: (2019)

Natural Course of Nonmalignant Partial Portal Vein Thrombosis in Cirrhotic Patients
por: Girleanu, Irina, et al.
Publicado: (2014)

Fondaparinux is effective for acute portal vein thrombosis in decompensated cirrhotic patients
por: Zhang, Zhi-Hao, et al.
Publicado: (2017)

Obesity is not associated with an increased risk of portal vein thrombosis in cirrhotic patients
por: Zakko, Alan, et al.
Publicado: (2018)

Protein S for Portal Vein Thrombosis in Cirrhotic Patients Waiting for Liver Transplantation
por: Hung, Hao-Chien, et al.
Publicado: (2020)

Nonselective beta-blockers may lead to stage 2 acute kidney injury and waitlist mortality in child class C cirrhosis
por: Lai, Mason, et al.
Publicado: (2023)

Usage of Direct Acting Oral Anticoagulants in Cirrhotic and Non-Cirrhotic Portal Vein Thrombosis: A Systematic Review
por: Gupta, Sachin, et al.
Publicado: (2021)

Gastrointestinal and liver manifestations of COVID-19
por: Cheong, Janice, et al.
Publicado: (2020)

Portal vein thrombosis leading to pre-sinusoidal non-cirrhotic portal hypertension resulting in decreased synthetic function of the liver
por: Kline, Kevin, et al.
Publicado: (2019)

The Incidence of Venous Thromboembolism and Practice of Deep Venous Thrombosis Prophylaxis Among Hospitalized Cirrhotic Patients
por: Alsheikh, Mira, et al.
Publicado: (2022)

Is there any vindication for low dose nonselective β-blocker medication in patients with liver cirrhosis?
por: Kim, Tae Wan, et al.
Publicado: (2012)

An evaluation of the effects of nonselective and cardioselective β-blockers on wound healing in Sprague Dawley rats
por: Raut, Sanket B., et al.
Publicado: (2012)

Serum omentin and vaspin levels in cirrhotic patients with and without portal vein thrombosis
por: Kukla, Michał, et al.
Publicado: (2017)

COVID-19 in Cirrhotic Patients: Is Portal Vein Thrombosis a Potential Complication?
por: Hassnine, Alshymaa A, et al.
Publicado: (2022)

Is the use of non-selective beta-blockers necessary in cirrhotic patients with small varices?
por: Qi, Xingshun, et al.
Publicado: (2014)

Adherence to Non-Selective Beta Blockers for Prevention of Variceal Bleeding in Cirrhotic Patients
por: An, Yang, et al.
Publicado: (2021)

Angiotensin receptor blocker add-on therapy in portal hypertension: To use angiotensin receptor blocker or not to use, that is the question
por: Lee, Hyun Woong
Publicado: (2014)

The incidence of venous thromboembolism and practice of deep venous thrombosis prophylaxis in hospitalized cirrhotic patients
por: Aldawood, Abdulaziz, et al.
Publicado: (2011)

Prevalence of chronic venous insufficiency and deep vein thrombosis in cirrhotic patients
por: da Cruz Renó, Leonardo, et al.
Publicado: (2023)

Exploration on the Effect of Nonselective β-Receptor Blockers (NSBBs) on Hemodynamic Parameters in Complicated Liver Cirrhosis
por: Mao, Gang, et al.
Publicado: (2022)

Portal vein thrombosis in cirrhotic patients - it is always the small pieces that make the big picture
por: Gîrleanu, Irina, et al.
Publicado: (2018)

Direct oral anticoagulant administration in cirrhotic patients with portal vein thrombosis: What is the evidence?
por: Biolato, Marco, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_apso11nkq7dja4r2c9p2pvmd08